IMGN

Immunogen Inc
IMGN

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

180 hedge funds and large institutions have $691M invested in Immunogen Inc in 2017 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 43 increasing their positions, 58 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more call options, than puts

Call options by funds: $ | Put options by funds: $

26% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 58

Holders
180
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.99M
Puts
$5.38M
Net Calls
Net Calls Change

Top Buyers

1
+$23.2M
2
+$21.8M
3
+$21.5M
4
State Street
State Street
Massachusetts
+$15.6M
5
O
OrbiMed
New York
+$11.6M

Top Sellers

1
-$10.9M
2
-$4.85M
3
-$3.59M
4
Goldman Sachs
Goldman Sachs
New York
-$3.35M
5
BBA
Baker Bros. Advisors
New York
-$2.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4.8M
27
$4.52M
28
$4.36M
29
$4.2M
30
$4.01M
31
$3.75M
32
$3.5M
33
$3.38M
34
$2.9M
35
$2.58M
36
$2.56M
37
$2.38M
38
$2.25M
39
$2.19M
40
$1.9M
41
$1.87M
42
$1.86M
43
$1.78M
44
$1.69M
45
$1.59M
46
$1.56M
47
$1.53M
48
$1.49M
49
$1.45M
50
$1.27M
1
2
3 4 5